p

pSivida

147 employees

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

Basic info

Industry

biotechnology research

Sectors

Glaucoma
Biotechnology
Health Care
Eye Disease
Retinal Disease
WetAMD
Optometry
Medical
Pharmaceutical
Ophthalmology

Date founded

1987

Funding rounds raised

Total raised

$60M

from 3 investors over 3 rounds

p

pSivida raised $16M on January 3, 2021

Investors: Ocumension

p

pSivida raised $60M on February 13, 2019

Investors: CRG LP

p

pSivida raised $7M on March 13, 2014

Investors: RA Capital Management, L.P.

FAQ